AKT1 and Cognitive impairment: In addition, OP treatment inhibited the decreased expression levels of PI3K, p-PI3K, AKT, and p-AKT in the hippocampus of Aβ1–42-induced AD model mice and increased the expression level of p-GSK-3β to improve metabolic function and cognitive impairment [20].